MARÍA CARMEN
MUÑOZ VILLAFRANCA
Hospital Universitario de Basurto
Bilbao, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Basurto (11)
2024
-
Inflammatory Bowel Disease: A Comprehensive Analysis of Molecular Bases, Predictive Biomarkers, Diagnostic Methods, and Therapeutic Options
International Journal of Molecular Sciences, Vol. 25, Núm. 13
-
Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA
Pharmaceutics, Vol. 16, Núm. 5
2023
-
Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety
American Journal of Gastroenterology, Vol. 118, Núm. 7, pp. 1237-1247
2022
2021
-
Ustekinumab treatment for toxic megacolon in severe colonic Crohn's disease
Revista Espanola de Enfermedades Digestivas, Vol. 113, Núm. 3, pp. 189-192
2019
-
Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study
Journal of Crohn's & colitis, Vol. 13, Núm. 12, pp. 1492-1500
2018
-
Adalimumab treatment of anti-TNF-naïve patients with ulcerative colitis: Deep remission and response factors
Digestive and Liver Disease, Vol. 50, Núm. 8, pp. 812-819
-
Infliximab as treatment of severe enteropathy in a patient with common variable immunodeficiency and cytomegalovirus infection
Gastroenterologia y Hepatologia, Vol. 41, Núm. 3, pp. 163-164
2016
-
Evolución clínica tras la suspensión de infliximab en pacientes con colitis ulcerosa en remisión profunda
Gastroenterologia y Hepatologia, Vol. 39, Núm. 7, pp. 442-448
2015
-
Pseudoaneurysm of the cystic artery: An uncommon cause of upper gastrointestinal bleeding in a case of xanthogranulomatous cholecystitis
Revista Espanola de Enfermedades Digestivas
2013
-
Vasculitis por adalimumab en un paciente con enfermedad de Crohn
Gastroenterologia y Hepatologia